Aeterna Zentaris
AEZS
$2.08
Share price
5.05%
Change (1 day)
-45.83%
Change (1 year)
Categories
Revenue for Aeterna Zentaris (AEZS)
Revenue in 2023 (TTM): $6.86 M
According to Aeterna Zentaris's latest financial reports the company's current revenue (TTM) is $6.86 M. In 2022 the company made a revenue of $5.64 M an increase over the years 2021 revenue that were of $2.74 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Aeterna Zentaris from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $6.86 M | 21.67% |
| 2022 | $5.64 M | 105.61% |
| 2021 | $2.74 M | -24.89% |
| 2020 | $3.65 M | 586.47% |
| 2019 | $0.53 M | -98.02% |
| 2018 | $26.88 M | 2812.35% |
| 2017 | $0.92 M | 1.32% |
| 2016 | $0.91 M | 67.16% |
| 2015 | $0.54 M | 4854.55% |
| 2014 | $0.01 M | -99.82% |
| 2013 | $6.17 M | -81.66% |
| 2012 | $33.66 M | -6.62% |
| 2011 | $36.05 M | 30.14% |
| 2010 | $27.7 M | -56.19% |
| 2009 | $63.23 M | 64.37% |
| 2008 | $38.47 M | -8.45% |
| 2007 | $42.02 M | 1.36% |
| 2006 | $41.45 M | -82.84% |
| 2005 | $0.24 B | 27.52% |
| 2004 | $0.18 B | 50.28% |
| 2003 | $0.12 B | 94.26% |
| 2002 | $64.89 M | 135.37% |
| 2001 | $27.57 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $52.32 B | 762,403.64% | 🇨🇭 Switzerland |
 Sanofi SNY | $49.13 B | 716,014.31% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $44.93 B | 654,738.24% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $25.72 M | 274.95% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $0.78 B | 11,277.30% | 🇺🇸 USA |